Anti-hypertensive and cardioprotective activities of traditional Chinese medicine-derived polysaccharides: A review

Int J Biol Macromol. 2021 Aug 31:185:917-934. doi: 10.1016/j.ijbiomac.2021.07.008. Epub 2021 Jul 3.

Abstract

Cardiovascular diseases (CVDs), a leading cause of death in modern society, have become a major public health issue globally. Although numerous approaches have been proposed to reduce morbidity and mortality, the pursuit of pharmaceuticals with more preventive and/or therapeutic value remains a focus of attention. Being a vast treasure trove of natural drug molecules, Traditional Chinese Medicine (TCM) has a long history of clinical use in the prophylaxis and remedy of CVDs. Increasing lines of preclinical evidence have demonstrated the effectiveness of TCM-derived polysaccharides on hindering the progression of CVDs, e.g. hypertension, myocardial infarction. However, to the best of our knowledge, there are few reviews on the application of TCM-derived polysaccharides in combating CVDs. Hence, we provide an overview of primary literature on the anti-hypertensive and cardioprotective activities of herbal polysaccharides. Additionally, we also discuss the current limitations and propose a new hypothesis about how polysaccharides exert cardiovascular effects based on the metabolism of polysaccharides.

Keywords: Anti-hypertensive; Cardioprotective; Polysaccharide.

Publication types

  • Review

MeSH terms

  • Animals
  • Antihypertensive Agents / therapeutic use*
  • Cardiotonic Agents / therapeutic use*
  • Cardiovascular Diseases / etiology
  • Cardiovascular Diseases / prevention & control*
  • Disease Models, Animal
  • Drug Evaluation, Preclinical
  • Drugs, Chinese Herbal
  • Humans
  • Hypertension / complications
  • Hypertension / drug therapy*
  • Medicine, Chinese Traditional
  • Polysaccharides / therapeutic use*

Substances

  • Antihypertensive Agents
  • Cardiotonic Agents
  • Drugs, Chinese Herbal
  • Polysaccharides